Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK8 | P49336 | 12/20 | 0.45 |
| ▸ | MET | P08581 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4282370 | 0.85 | MAPT (0.43) | METNPC1RAB9APOLBMAPT | |
| SCHEMBL4282325 | 0.83 | NPC1 (0.39) | METNPC1RAB9AMAPTKDR | |
| SCHEMBL4280655 | 0.83 | BRAF (0.43) | METMAPTKDR | |
| SCHEMBL3513086 | 0.82 | CDK8 (0.41) | CDK8NPC1RAB9APOLBKDR | |
| SCHEMBL30435041 | 0.80 | CDK8 (0.48) | CDK8 | |
| SCHEMBL4280855 | 0.80 | MET (0.43) | CDK8METNPC1RAB9AMAPT | |
| SCHEMBL4880831 | 0.80 | HTT (0.51) | CDK8NPC1RAB9AKDR | |
| SCHEMBL4889660 | 0.79 | CDK8 (0.67) | CDK8 | |
| SCHEMBL4287982 | 0.79 | BRAF (0.57) | KDR | |
| SCHEMBL2855873 | 0.79 | GAA (0.53) | CDK8RAB9AMAPTKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2184285-B1 | HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2015-11-04 | — | — | EP | disclosed |
| EP-2184285-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2010-05-12 | — | — | EP | disclosed |